The Human Platelet Lysate Market is segmented by Type (Heparin-free Platelet Lysates, Human Platelet Lysates with Heparin), Application (Research Use, Clinical Use), End User (Academic and Research Institutes, Biopharmaceutical Companies, Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World).
The Human Platelet Lysate Market is segmented by Type (Heparin-free Platelet Lysates, Human Platelet Lysates with Heparin), Application (Research Use, Clinical Use), End User (Academic and Research Institutes, Biopharmaceutical Companies, Others), and Region ...
The Human Platelet Lysate Market is estimated to grow from USD 48.2 Million in 2020 to USD 59.8 Million by 2026 at a healthy CAGR of 3.7% during the forecast period.
Human Platelet Lysate (HPL) is a non-animal derived cell culture growth supplement that is obtained from blood platelets after freezing and thawing. It contains abundant factors and cytokines required for cell growth and proliferation. Platelet lysate can be utilized as a source of growth for replacing bovine serum in a cell culture medium.
Human Platelet Lysate MarketReport Overview
Market Size in 2026
USD 59.8 Million
Market Size in 2020
USD 48.2 Million
Market Growth (2021-2026)
CAGR of 3.7%
Base Year of Study
2020
Trend Period
2016-2019
Forecast Period
2021-2026
Key Players
Key players operating in the human platelet lysate market are-
Life Science Group Limited (Life Science Production) (India)
Trinova Biochem Gmbh (Germany)
Market Dynamics
Growing emphasis on funding & rise in research centers, government regulations, clinical and staff efficiency, product innovation, and user acceptance are some of the key driving factors propelling the growth of the human platelet lysate market during the review period. Also, rising awareness levels of blood donation coupled with increasing adoption of advanced blood collection & processing technology in developing countries is also anticipated to augment the human platelet lysate market growth.
COVID-19 Impact
The COVID-19 outbreak moderately affected the growth of the human platelet lysate market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. As the medical community is treating the infected patients, the research related to human platelet lysate was moderately impacted, thus resulting in fewer visits to clinics.
Based on application, the market has been bifurcated into research use and clinical use. The research use segment accounted for a substantial market share in 2020. The evolution of human platelet lysates has bolstered various experimental and clinical research studies. Also, growing government funding for life science-related projects and an increasing number of research centers and research institutes boost the segment growth.
Regional Trends
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure and favorable government initiatives. Moreover, rising innovations in technologically advanced products, immense per capita health expenditures, increasing numbers of chronic patients, which further proliferate the regional growth.
Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-
Distributors
Suppliers
Manufacturers
Logistics organizations
Government bodies
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the Human Platelet Lysate Market
How lucrative is the future?
Market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional and country level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
Merck KGaA (Germany), Compass Biomedical Inc. (US), Macopharma SA (France), Mill Creek Life Sciences Llc., Stemcell Technologies Inc. (Canada), Zen-Bio, Inc., Sclavo Diagnostics Interna-tional Srl. (Italy), Life Science Group Limited (Life Science Production) (India), and Trinova Bio-chem Gmbh (Germany) are among the key players in the human platelet lysate market.
Growing emphasis on funding & rise in research centers, government regulations, clinical and staff efficiency, product innovation, and user acceptance are some of the key driving factors propelling the growth of the human platelet lysate market during the review period. Also, rising awareness levels of blood donation coupled with increasing adoption of advanced blood collection & processing technology in developing countries is also anticipated to augment the human platelet lysate market growth.